文献速递帕金森病与运动障碍

识别帕金森病前驱期个体:一项前瞻性队列研究

Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study.
PubMed 文献 · Ann Neurol · 2024-12-19

该前瞻性队列纳入6108名男性,重复评估前驱期特征并随访帕金森病(PD)发生。平均随访3.4年新诊断PD 103例;便秘、 probable REM睡眠行为障碍(pRBD)与嗅觉减退三者共存者后续3年PD风险为无这些特征者的23.35倍,基于运动障碍学会(MDS)研究标准的前驱期PD概率≥0.8者风险为概率<0.2者的21.96倍。

要点

  • 便秘、pRBD与嗅觉减退三者共存者后续3年PD风险为无这些特征者的23.35倍。
  • MDS前驱期PD概率≥0.8者PD风险为概率<0.2者的21.96倍。
  • 两种复合指标预测价值相当,均强于任何单一特征。

核心结论

  • 关键体征与症状的组合可强预测未来临床显现的帕金森病,可能整合入筛查策略以识别可纳入PD预防试验的个体。

研究设计与样本

  • 前瞻性队列研究,纳入6108名男性,重复评估关键前驱期特征并前瞻性随访帕金森病发生。

主要发现

  • 平均随访3.4年期间新诊断帕金森病103例。
  • 便秘、pRBD与嗅觉减退三者共存的男性后续3年PD风险为无这些特征男性的23.35倍(RR=23.35,95%CI=10.62-51.33)。
  • MDS前驱期PD概率≥0.8的男性PD风险为概率<0.2者的21.96倍(RR=21.96,95%CI=11.17-43.17)。
  • 三种非运动特征共存与MDS概率≥0.8的预测价值相当,均强于任何单一特征。
  • 识别出2种前驱期PD亚型,RBD与视觉颜色损害为关键区分因素。

关键数值与推荐

  • 便秘、pRBD与嗅觉减退三者共存:后续3年PD风险RR=23.35(95%CI=10.62-51.33)。
  • MDS前驱期PD概率≥0.8 vs <0.2:PD风险RR=21.96(95%CI=11.17-43.17)。

临床怎么用

  • 作者认为这些复合指标可整合入筛查策略,以识别可纳入PD预防试验的个体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We prospectively evaluated how well combinations of signs and symptoms can identify individuals in the prodromal phase of Parkinson's disease (PD). METHODS: The study comprised 6,108 men who underwent repeated assessments of key prodromal features and were prospectively followed for the development of PD. Two composite measures of prodromal PD were evaluated: (i) the co-occurrence of constipation, probable rapid eye movement (REM) sleep behavior disorder (pRBD), and hyposmia, and (ii) the probability of prodromal PD based on the Movement Disorders Society (MDS) research criteria. We also examined the progression and heterogeneity of the prodromal PD phase. RESULTS: One hundred three individuals were newly diagnosed with PD over an average follow-up of 3.4 years. Men with constipation, pRBD, and hyposmia had a 23-fold higher risk of receiving a PD diagnosis in the subsequent 3 years, compared with men without these features (risk ratio [RR] = 23.35, 95% confidence interval [CI] = 10.62-51.33). The risk of PD was 21-fold higher in men with a probability of prodromal PD ≥ 0.8 compared with those with a probability < 0.2 (RR = 21.96, 95% CI = 11.17-43.17). Both the co-occurrence of the 3 non-motor features and an MDS-based probability ≥ 0.8 had comparable predictive values, and both were stronger predictors of PD than any of the features individually. We identified 2 prodromal PD subtypes where RBD and visual color impairment were key discriminators. INTERPRETATION: Our study demonstrates that combinations of key signs and symptoms strongly predict future clinically manifest PD. These measures may be integrated into screening strategies to identify individuals who could be targeted for enrollment into PD prevention trials. ANN NEUROL 2025;97:720-729.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Flores-Torres MH, Hughes KC, Cortese M, et al. Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study. Ann Neurol. 2024. PMID: 39702948. doi:10.1002/ana.27166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。